Chao Huang

发表

[99mTc]3PRGD2 for integrin receptor imaging of esophageal cancer: a comparative study with [18F]FDG PET/CT

Shan Zheng, Yun Chen, Wei-bing Miao, 2018, Annals of Nuclear Medicine.

Evaluation of 99mTc-3PRGD2 integrin receptor imaging in hepatocellular carcinoma tumour-bearing mice: comparison with 18F-FDG metabolic imaging

Jieling Zheng, Wei-bing Miao, Chao Huang, 2017, Annals of Nuclear Medicine.

Study of novel molecular probe 99mTc-3PRGD2 in the diagnosis of rheumatoid arthritis

Qing Zheng, Wei-bing Miao, Chao Huang, 2015, Nuclear medicine communications.

Application of 99mTc-3PRGD2 Imaging for Early Prediction of Pathological Response to Neoadjuvant Chemotherapy in Breast Tumors and Axillary Lymph Nodes

Chuan Wang, F. Fu, Shan Zheng, 2020 .

CXCR4-Directed PET/CT with [68Ga]Pentixafor in Central Nervous System Lymphoma: A Comparison with [18F]FDG PET/CT

Aihong Chen, Shaobo Yao, Apeng Yang, 2021, Molecular Imaging and Biology.

Accurate preoperative staging with [68Ga]Ga-FAPI PET/CT for patients with oral squamous cell carcinoma: a comparison to 2-[18F]FDG PET/CT

Shaobo Yao, Shan Zheng, Shaoming Chen, 2022, European Radiology.

Comparison of [99mTc]3PRGD2 Imaging and [18F]FDG PET/CT in Breast Cancer and Expression of Integrin αvβ3 in Breast Cancer Vascular Endothelial Cells

Bing Jia, Zhaohui Zhu, Ying-hong Yang, 2018, Molecular Imaging and Biology.

Using Radiomics to Differentiate Brain Metastases From Lung Cancer Versus Breast Cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status

Xiaoyu Wang, Ziyan Pang, Chao Huang, 2023, Journal of computer assisted tomography.

Burkitt Lymphoma/Leukemia Presented on 68Ga-Pentixafor and 18F-FDG PET/CT.

Shaobo Yao, Qianqian Xue, Wei-bing Miao, 2021, Clinical nuclear medicine.